Capitalizing a Cure

How Finance Controls the Price and Value of Medicines

Victor Roy

$57.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

California Uni Pr Trade
20 April 2023

Sociology; Industry & industrial studies; Manufacturing industries; Medicine; Medical ethics & professional conduct; Health systems & services

A free open access ebook is available upon publication. Learn more at www.luminosoa.org.

Capitalizing a Cure takes readers into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir-based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. But their sticker shock—the drug was dubbed ""the $1,000-a-day pill""—intensified a global debate over the pricing of new medicines. Weaving extensive historical research with insights from political economy and science and technology studies, Victor Roy demystifies an oft-missed dynamic in this debate: the reach of financialized capitalism into how medicines are made, priced, and valued.

Roy's account moves between public and private labs, Wall Street and corporate board rooms, public health meetings and health centers to trace the ways sofosbuvir-based medicines became financial assets dominated by strategies of speculation and extraction at the expense of access and care. Provocative and sobering, this book illuminates the harmful impact of allowing financial markets to supersede democracy and human health and points to the necessary work of building more equitable futures.

By: Victor Roy
Imprint: California Uni Pr Trade
Country of Publication: United States
Dimensions: Height: 229mm, Width: 152mm, Spine: 15mm
Weight: 363g
ISBN: 9780520388710
ISBN 10: 0520388712
Pages: 245
Publication Date: 20 April 2023
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Victor Roy, MD, PhD, is a family physician, sociologist, and a fellow in the National Clinician Scholars Program at Yale University.

Reviews for Capitalizing a Cure: How Finance Controls the Price and Value of Medicines

Roy convincingly shows through this example how venture capital, Wall Street, and the industry's top executives have turned small biotechnology firms and Big Pharma corporations into vehicles for extracting wealth from the health care system, even as these ostensibly health-promoting companies deny access to millions of needy people at home and abroad and undermine the financial well-being of patients and payers. * Washington Monthly *